Cargando…

α(1)-Antitrypsin and the serpins: variation and countervariation

α(1)-Antitrypsin is a plasma protein which protects elastic tissue from proteolytic attack. Consequently, genetic deficiency, or the oxidation of its reactive centre in cigarette smokers can result in the degenerative lung disease emphysema. Structural studies explain the mechanisms involved and hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrell, Robin, Travis, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 1985
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172600/
http://dx.doi.org/10.1016/0968-0004(85)90011-8
_version_ 1783524285537583104
author Carrell, Robin
Travis, James
author_facet Carrell, Robin
Travis, James
author_sort Carrell, Robin
collection PubMed
description α(1)-Antitrypsin is a plasma protein which protects elastic tissue from proteolytic attack. Consequently, genetic deficiency, or the oxidation of its reactive centre in cigarette smokers can result in the degenerative lung disease emphysema. Structural studies explain the mechanisms involved and have also drawn attention to a new family of serine proteinase inhibitors. The specificity of each of these inhibitors is primarily dependent on a single amino acid at its reactive centre. Site-directed mutagenesis is enabling the production of specifically designed inhibitors for therapeutic use, including an improved replacement for α(1)-antitrypsin deficiency.
format Online
Article
Text
id pubmed-7172600
institution National Center for Biotechnology Information
language English
publishDate 1985
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71726002020-04-22 α(1)-Antitrypsin and the serpins: variation and countervariation Carrell, Robin Travis, James Trends Biochem Sci Article α(1)-Antitrypsin is a plasma protein which protects elastic tissue from proteolytic attack. Consequently, genetic deficiency, or the oxidation of its reactive centre in cigarette smokers can result in the degenerative lung disease emphysema. Structural studies explain the mechanisms involved and have also drawn attention to a new family of serine proteinase inhibitors. The specificity of each of these inhibitors is primarily dependent on a single amino acid at its reactive centre. Site-directed mutagenesis is enabling the production of specifically designed inhibitors for therapeutic use, including an improved replacement for α(1)-antitrypsin deficiency. Published by Elsevier Ltd. 1985-01 2003-03-14 /pmc/articles/PMC7172600/ http://dx.doi.org/10.1016/0968-0004(85)90011-8 Text en Copyright © 1985 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Carrell, Robin
Travis, James
α(1)-Antitrypsin and the serpins: variation and countervariation
title α(1)-Antitrypsin and the serpins: variation and countervariation
title_full α(1)-Antitrypsin and the serpins: variation and countervariation
title_fullStr α(1)-Antitrypsin and the serpins: variation and countervariation
title_full_unstemmed α(1)-Antitrypsin and the serpins: variation and countervariation
title_short α(1)-Antitrypsin and the serpins: variation and countervariation
title_sort α(1)-antitrypsin and the serpins: variation and countervariation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172600/
http://dx.doi.org/10.1016/0968-0004(85)90011-8
work_keys_str_mv AT carrellrobin a1antitrypsinandtheserpinsvariationandcountervariation
AT travisjames a1antitrypsinandtheserpinsvariationandcountervariation